E-mail:gzliang@cqu.edu.cn    Tel: (86)2365102507

List of peptide properties
DFBP ID - DFBPOPIO0038(Opioid peptide)
DFBP ID DFBPOPIO0038
Peptide sequence YVPFP
Type Native peptide
Peptide/Function name Opioid peptide, as1-Casomorphin
Function-activity relationship
Main bioactivity Opioid activity
Otheir bioactivity Anticancer activity [D1]
Calculated physicochemical properties
Three-letter amino acid Tyr-Val-Pro-Phe-Pro
Single-letter amino acid YVPFP
Peptide length 5
Peptide mass
Experimental mass Theoretical mass
N.D 621.73 Da c
Net charge 0.00 c
Isoelectric point (pI) 5.92 c
IC50 N.D
pIC50 N.D
GRAVY 0.5000 c
Hydrophilic residue ratio 80% c
Peptide calculator
To calculate the physicochemical properties of bioactive peptide.
Peptide source & Food-borne protein(s) search
Classification Human
Organism/Source Human milk
Precursor protein αs1-Casein
Residue position

f(158-162)

Precursor protein(s) search
Link-research
There are no literature reports on the discovery of this sequence in other food-source proteins.
Biological/Functional activity & target protein
Opioid activity αs1-Casomorphin was found to bind with high affinity to all three subtypes of the κ-opioid receptor (κ13). When amidated at the C-terminus, αs1-casomorphin amide binds to the δ- and κ3-opioid sites. Both αs1-casomorphin and its amide inhibit in a dose- dependent and reversible manner the proliferation of T47D human breast cancer cells. This anti-proliferative activity was greater for αs1-casomorphin, which was the most potent opioid in inhibiting T47D cell proliferation, as shown in table 1.
Table 1 Affinity of αs1-casomorphin and αs1-casomorphin amide for opioid binding sites in T47D human breastcells and rat brain membranes
Ligand
Affinity (nM)
Effector
αs1-Casomorphin
αs1-Casomorphin amide
Detected opioid sites
T47D cells
[3H]Ethylketocyclazocine

0.1
> 1000
ξ, κ1, κ2
[3H]Ethylketocyclazocine10 μM DADLE
0.7
> 1000
κ1
[3H]Diprenorphine
0.5
0.12
ξ, κ2, κ3
[3H]Diprenorphine10 μM DADLE0.006
0.2
κ3
[3H]DPDPE
> 1000
1.7
δ
Rat brain membranes
[3H]DSLET
2600
> 10000
δ
[3H]DAGO
> 10000
1000
μ

Opioid agonist/antagonist, μ / δ <<< κ [1].

Specific target protein(s) Specific Target Protein(s):
Kappa-type opioid receptor
Delta-type opioid receptor
Taste properties & Structure
Bitterness
Literature report N.D
Bitter prediction tools Bitter taste prediction
SMILES N[C@@]([H])(Cc1ccc(O)cc1)C(=O)N[C@@]([H])(C(C)C)C(=O)N1[C@@]([H])(CCC1)C(=O)N[C@@]([H])(Cc1ccccc1)C(=O)N1[C@@]([H])(CCC1)C(=O)O
Preparation method
Mode of preparation

Synthesis peptide

Enzyme(s)/starter culture

The peptide was synthesized by conventional peptide chemistry methods.

Stability & Cytotoxicity
Peptide stability
Literature report: N.D
EHP-Tool: Enzymatic Hydrolysis Prediction Tool (EHP-Tool)
Peptide cytotoxicity
Literature report: N.D
Prediction: ToxinPred
Additional information
Additional information N.D
Database cross-references
DFBP
[D1] DFBPANCA0651
BIOPEP-UWM [D2] 2861
APD [D3] -
BioPepDB [D4] -
MBPDB [D5] -
Reference(s)
Primary literature Kampa M, Loukas S, Hatzoglou A, Martin P, Martin PM, Castanas E. Identification of a novel opioid peptide (Tyr-Val-Pro-Phe-Pro) derived from human alpha S1 casein (alpha S1-casomorphin, and alpha S1-casomorphin amide). Biochem J. 1996 Nov 1;319 ( Pt 3)(Pt 3):903-8.
PMID: 8920997
Other literature(s)

[1] Teschemacher H. Opioid receptor ligands derived from food proteins.[J]. Current Pharmaceutical Design, 2003, 9(16):-.

PubDate 1996
Copyright © 2020. Record / license number: Chongqing ICP No. 2000214